KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Rad Laboratories (BIO) Non-Current Assets (2016 - 2025)

Bio-Rad Laboratories (BIO) has disclosed Non-Current Assets for 17 consecutive years, with $7.7 billion as the latest value for Q4 2025.

  • On a quarterly basis, Non-Current Assets rose 21.1% to $7.7 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $18.9 billion, a 1022.68% increase, with the full-year FY2025 number at $7.7 billion, up 21.1% from a year prior.
  • Non-Current Assets was $7.7 billion for Q4 2025 at Bio-Rad Laboratories, up from $6.9 billion in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $17.5 billion in Q3 2021 to a low of -$3.1 billion in Q2 2024.
  • A 5-year average of $4.8 billion and a median of $6.9 billion in 2025 define the central range for Non-Current Assets.
  • Peak YoY movement for Non-Current Assets: skyrocketed 735.76% in 2022, then plummeted 129.21% in 2024.
  • Bio-Rad Laboratories' Non-Current Assets stood at -$1.6 billion in 2021, then surged by 735.76% to $10.3 billion in 2022, then crashed by 126.69% to -$2.8 billion in 2023, then soared by 329.39% to $6.3 billion in 2024, then rose by 21.1% to $7.7 billion in 2025.
  • Per Business Quant, the three most recent readings for BIO's Non-Current Assets are $7.7 billion (Q4 2025), $6.9 billion (Q3 2025), and $7.4 billion (Q2 2025).